Status:
COMPLETED
Safety and Efficacy Study of an Iontophoretic Patch Containing Lidocaine and Epinephrine for Venipuncture in Healthy Adult Volunteers
Lead Sponsor:
Dharma Therapeutics Inc.
Conditions:
Local Anesthesia
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the effectiveness of administering Lidocaine and Epinephrine using an iontophoretic device treatment to provide local anesthesia to healthy adult volunteer sub...
Eligibility Criteria
Inclusion
- Subjects may be of any race, either sex, and must be \>18 years of age
- Healthy subjects as per medical screening
- Subjects must have intact, healthy skin (no tattoos, surgical scars, skin infections, etc.) where the iontophoresis treatment will be performed
- Subjects must be alert, oriented, mentally competent, and able to understand and comply with the requirements of the study
- Subjects must have signed and dated a written informed consent
- Female subjects of childbearing potential must have a negative pregnancy test result prior to the iontophoresis treatment
Exclusion
- Subjects with a known allergy or sensitivity to lidocaine, epinephrine or other local anesthetics of the amide or ester type
- Subjects with a know sensitivity to any components (e.g. adhesives) of the IDDSSubjects who have undergone venipuncture in the treatment area within the prior 2 weeks or longer if bruising or hematoma is apparent
- Subjects who have taken an analgesic pain medication during the 24-hour period prior to the venipuncture in the posterior surface of the hand
- Subjects with skin allergies or have skin diseases (e.g. psoriasis, eczema
- Subjects with an open skin lesion at the treatment site
- Subjects who are pregnant or breastfeeding
- Subjects exposed to an investigational drug or device within the past 30 days or are involved concurrently in other treatment clinical trials
- Subjects who participated in previous DTI/Transcu clinical studies related to this product
- Subjects with known concurrent illness
- Subjects with "current" known/admitted substance abuse (alcohol/drug)
- Subjects with pacemakers and/or externally mounted electronic devices
- Current or history of conditions that contraindicate use of iontophoretic treatment or venipuncture
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2009
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00889642
Start Date
May 1 2009
End Date
June 1 2009
Last Update
June 23 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Advanced Clinical Research Institute
Anaheim, California, United States, 92801
2
Vince & Associates Clinical Research
Overland Park, Missouri, United States, 66212